Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Recruiting now

Conditions studied: Malignant Neoplasm

In brief

This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.

Key facts

Study ID
NCT02688517
Run by
Rutgers, The State University of New Jersey
People needed
1100
Starts
2013-02-01
Expected to finish
2030-05-01
Last updated by the study team
2026-04-17

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.